Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Stroke | 393 | 2024 | 9981 | 20.900 |
Why?
|
Brain Ischemia | 196 | 2024 | 3265 | 16.670 |
Why?
|
Tissue Plasminogen Activator | 110 | 2024 | 1261 | 15.020 |
Why?
|
Thrombolytic Therapy | 127 | 2024 | 2161 | 12.080 |
Why?
|
Fibrinolytic Agents | 108 | 2024 | 2158 | 10.850 |
Why?
|
Telemedicine | 50 | 2023 | 2872 | 5.240 |
Why?
|
Guideline Adherence | 58 | 2021 | 2266 | 4.170 |
Why?
|
Thrombectomy | 35 | 2024 | 680 | 3.970 |
Why?
|
Ischemic Attack, Transient | 41 | 2023 | 935 | 3.820 |
Why?
|
Registries | 104 | 2023 | 8089 | 3.500 |
Why?
|
Delivery of Health Care, Integrated | 12 | 2021 | 941 | 3.480 |
Why?
|
Endovascular Procedures | 28 | 2023 | 1979 | 3.140 |
Why?
|
Hospital Mortality | 68 | 2023 | 5317 | 3.090 |
Why?
|
American Heart Association | 38 | 2022 | 1056 | 2.900 |
Why?
|
Cerebral Hemorrhage | 40 | 2024 | 2647 | 2.870 |
Why?
|
Neurology | 13 | 2022 | 763 | 2.710 |
Why?
|
Hospitals | 43 | 2023 | 3952 | 2.610 |
Why?
|
Patient Transfer | 18 | 2023 | 761 | 2.600 |
Why?
|
Quality of Health Care | 47 | 2020 | 4371 | 2.530 |
Why?
|
Practice Guidelines as Topic | 66 | 2021 | 7279 | 2.310 |
Why?
|
Quality Indicators, Health Care | 26 | 2021 | 1831 | 2.250 |
Why?
|
Intracranial Hemorrhages | 27 | 2024 | 855 | 2.220 |
Why?
|
Quality Improvement | 45 | 2023 | 3749 | 2.170 |
Why?
|
Remote Consultation | 9 | 2021 | 238 | 2.030 |
Why?
|
Atrial Fibrillation | 27 | 2023 | 5034 | 1.990 |
Why?
|
Aged, 80 and over | 214 | 2024 | 57776 | 1.980 |
Why?
|
Aged | 335 | 2024 | 163280 | 1.890 |
Why?
|
Emergency Medical Services | 25 | 2022 | 1917 | 1.760 |
Why?
|
Humans | 560 | 2024 | 744343 | 1.600 |
Why?
|
Triage | 10 | 2021 | 976 | 1.600 |
Why?
|
Treatment Outcome | 153 | 2024 | 63114 | 1.590 |
Why?
|
United States | 181 | 2024 | 69872 | 1.550 |
Why?
|
Reperfusion | 14 | 2024 | 284 | 1.490 |
Why?
|
Male | 355 | 2024 | 350118 | 1.440 |
Why?
|
Patient Admission | 10 | 2019 | 1380 | 1.430 |
Why?
|
Patient Discharge | 38 | 2022 | 3313 | 1.390 |
Why?
|
Female | 361 | 2024 | 380194 | 1.380 |
Why?
|
Hospitalization | 46 | 2022 | 10262 | 1.370 |
Why?
|
Anticoagulants | 27 | 2023 | 4599 | 1.340 |
Why?
|
Subarachnoid Hemorrhage | 10 | 2021 | 1018 | 1.320 |
Why?
|
Hospitals, Special | 6 | 2015 | 101 | 1.280 |
Why?
|
Cerebral Infarction | 20 | 2022 | 1011 | 1.270 |
Why?
|
Middle Aged | 247 | 2024 | 213383 | 1.260 |
Why?
|
Severity of Illness Index | 33 | 2020 | 15540 | 1.210 |
Why?
|
Warfarin | 11 | 2021 | 1496 | 1.200 |
Why?
|
Delivery of Health Care | 16 | 2022 | 5319 | 1.190 |
Why?
|
Time Factors | 91 | 2022 | 40075 | 1.180 |
Why?
|
Infarction, Middle Cerebral Artery | 11 | 2024 | 475 | 1.170 |
Why?
|
Nervous System Diseases | 6 | 2022 | 1622 | 1.120 |
Why?
|
Infusions, Intravenous | 22 | 2020 | 2274 | 1.080 |
Why?
|
Certification | 8 | 2020 | 424 | 1.010 |
Why?
|
Medicare | 38 | 2023 | 6566 | 0.950 |
Why?
|
Retrospective Studies | 109 | 2024 | 77449 | 0.950 |
Why?
|
Recovery of Function | 17 | 2023 | 2925 | 0.930 |
Why?
|
Encephalocele | 3 | 2014 | 136 | 0.930 |
Why?
|
Brain Death | 3 | 2021 | 348 | 0.900 |
Why?
|
Acute Disease | 42 | 2019 | 7149 | 0.850 |
Why?
|
Patient Selection | 12 | 2019 | 4215 | 0.830 |
Why?
|
Spinal Puncture | 3 | 2014 | 281 | 0.830 |
Why?
|
Diffusion Magnetic Resonance Imaging | 21 | 2020 | 2737 | 0.830 |
Why?
|
Cerebral Angiography | 17 | 2018 | 1285 | 0.830 |
Why?
|
Logistic Models | 34 | 2023 | 13408 | 0.810 |
Why?
|
Disability Evaluation | 11 | 2018 | 1827 | 0.810 |
Why?
|
Anesthesia, Epidural | 2 | 2014 | 228 | 0.800 |
Why?
|
Risk Factors | 84 | 2023 | 72290 | 0.800 |
Why?
|
Intracranial Pressure | 2 | 2014 | 326 | 0.790 |
Why?
|
Cerebrovascular Disorders | 13 | 2018 | 1504 | 0.780 |
Why?
|
Anesthesia, Obstetrical | 2 | 2014 | 235 | 0.780 |
Why?
|
Arterial Occlusive Diseases | 8 | 2022 | 793 | 0.760 |
Why?
|
Tomography, X-Ray Computed | 41 | 2023 | 20129 | 0.740 |
Why?
|
Cerebrovascular Circulation | 27 | 2020 | 2731 | 0.730 |
Why?
|
Skilled Nursing Facilities | 6 | 2018 | 372 | 0.730 |
Why?
|
Neurologic Examination | 3 | 2021 | 930 | 0.730 |
Why?
|
Decision Support Techniques | 6 | 2021 | 1956 | 0.720 |
Why?
|
Hospital Communication Systems | 1 | 2020 | 51 | 0.720 |
Why?
|
Healthcare Disparities | 14 | 2021 | 3158 | 0.700 |
Why?
|
Plasminogen Activators | 5 | 2016 | 209 | 0.680 |
Why?
|
Odds Ratio | 26 | 2021 | 9849 | 0.680 |
Why?
|
Centralized Hospital Services | 1 | 2018 | 18 | 0.670 |
Why?
|
Videoconferencing | 5 | 2019 | 195 | 0.660 |
Why?
|
Platelet Aggregation Inhibitors | 14 | 2022 | 3068 | 0.650 |
Why?
|
New England | 6 | 2021 | 1022 | 0.640 |
Why?
|
Ischemia | 5 | 2018 | 1907 | 0.640 |
Why?
|
Academic Medical Centers | 8 | 2020 | 2759 | 0.640 |
Why?
|
Secondary Prevention | 16 | 2022 | 1530 | 0.640 |
Why?
|
Multivariate Analysis | 27 | 2019 | 12245 | 0.640 |
Why?
|
Regional Health Planning | 1 | 2018 | 97 | 0.630 |
Why?
|
Databases, Factual | 22 | 2021 | 7729 | 0.630 |
Why?
|
Emergency Service, Hospital | 14 | 2021 | 7659 | 0.620 |
Why?
|
Myocardial Reperfusion | 2 | 2017 | 351 | 0.620 |
Why?
|
Perfusion Imaging | 5 | 2024 | 195 | 0.620 |
Why?
|
Office Visits | 2 | 2021 | 598 | 0.620 |
Why?
|
Risk Assessment | 34 | 2022 | 23338 | 0.610 |
Why?
|
Advisory Committees | 2 | 2014 | 775 | 0.610 |
Why?
|
Cerebral Amyloid Angiopathy | 4 | 2023 | 859 | 0.610 |
Why?
|
Program Evaluation | 9 | 2020 | 2488 | 0.600 |
Why?
|
Language | 5 | 2022 | 1471 | 0.590 |
Why?
|
Collateral Circulation | 2 | 2017 | 287 | 0.590 |
Why?
|
Vitamin K | 3 | 2023 | 295 | 0.590 |
Why?
|
Health Planning Guidelines | 3 | 2010 | 163 | 0.590 |
Why?
|
Heart Failure | 13 | 2024 | 10900 | 0.580 |
Why?
|
Rehabilitation Centers | 3 | 2015 | 254 | 0.570 |
Why?
|
Quality Assurance, Health Care | 7 | 2012 | 2212 | 0.560 |
Why?
|
Cohort Studies | 50 | 2024 | 40561 | 0.560 |
Why?
|
Embolism, Paradoxical | 1 | 2016 | 58 | 0.540 |
Why?
|
Foramen Ovale, Patent | 3 | 2016 | 223 | 0.540 |
Why?
|
Lipoproteins, LDL | 3 | 2010 | 640 | 0.530 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2017 | 1873 | 0.530 |
Why?
|
Aerospace Medicine | 1 | 2016 | 84 | 0.530 |
Why?
|
Magnetic Resonance Imaging | 48 | 2023 | 35421 | 0.510 |
Why?
|
Prospective Studies | 45 | 2024 | 53288 | 0.510 |
Why?
|
Inpatients | 6 | 2021 | 2518 | 0.500 |
Why?
|
Electrocardiography, Ambulatory | 5 | 2022 | 585 | 0.500 |
Why?
|
User-Computer Interface | 1 | 2021 | 1431 | 0.500 |
Why?
|
Age Factors | 26 | 2022 | 18370 | 0.500 |
Why?
|
Monitoring, Ambulatory | 1 | 2018 | 355 | 0.500 |
Why?
|
Neurosurgical Procedures | 3 | 2021 | 2002 | 0.490 |
Why?
|
Ambulatory Care Facilities | 3 | 2020 | 933 | 0.490 |
Why?
|
Regional Medical Programs | 2 | 2012 | 71 | 0.490 |
Why?
|
Brain Infarction | 4 | 2012 | 299 | 0.480 |
Why?
|
Sex Characteristics | 5 | 2022 | 2585 | 0.480 |
Why?
|
Referral and Consultation | 6 | 2022 | 3528 | 0.470 |
Why?
|
Medically Uninsured | 4 | 2023 | 853 | 0.470 |
Why?
|
Congresses as Topic | 1 | 2018 | 764 | 0.470 |
Why?
|
Societies, Medical | 6 | 2019 | 3743 | 0.460 |
Why?
|
Chi-Square Distribution | 12 | 2015 | 3508 | 0.460 |
Why?
|
Myocardial Infarction | 16 | 2019 | 11727 | 0.460 |
Why?
|
Puerperal Disorders | 1 | 2015 | 275 | 0.440 |
Why?
|
Medicine | 2 | 2018 | 946 | 0.440 |
Why?
|
Health Services Needs and Demand | 3 | 2020 | 1411 | 0.430 |
Why?
|
Efficiency, Organizational | 5 | 2019 | 695 | 0.420 |
Why?
|
Pandemics | 10 | 2024 | 8388 | 0.410 |
Why?
|
Medical Oncology | 1 | 2024 | 2265 | 0.410 |
Why?
|
Smoking | 9 | 2023 | 8987 | 0.410 |
Why?
|
Cardiomyopathies | 2 | 2023 | 1912 | 0.410 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2214 | 0.400 |
Why?
|
Siderosis | 2 | 2023 | 102 | 0.400 |
Why?
|
Public-Private Sector Partnerships | 1 | 2012 | 121 | 0.400 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1049 | 0.400 |
Why?
|
Sex Factors | 16 | 2022 | 10397 | 0.400 |
Why?
|
Behavior Therapy | 1 | 2017 | 865 | 0.390 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 1 | 2021 | 53 | 0.390 |
Why?
|
Evidence-Based Medicine | 12 | 2018 | 3610 | 0.380 |
Why?
|
Emergency Treatment | 3 | 2020 | 517 | 0.380 |
Why?
|
Internationality | 2 | 2016 | 1003 | 0.380 |
Why?
|
Attitude of Health Personnel | 4 | 2020 | 3843 | 0.380 |
Why?
|
Antifibrinolytic Agents | 2 | 2010 | 254 | 0.370 |
Why?
|
Progesterone | 1 | 2014 | 776 | 0.360 |
Why?
|
Health Policy | 6 | 2013 | 2661 | 0.360 |
Why?
|
Telephone | 2 | 2012 | 617 | 0.360 |
Why?
|
Patient-Centered Care | 3 | 2016 | 1439 | 0.360 |
Why?
|
Insurance Coverage | 4 | 2023 | 1901 | 0.350 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2009 | 292 | 0.350 |
Why?
|
Pneumonia, Bacterial | 1 | 2013 | 316 | 0.350 |
Why?
|
Program Development | 3 | 2011 | 1316 | 0.350 |
Why?
|
Administration, Oral | 12 | 2023 | 3913 | 0.350 |
Why?
|
Anemia, Sickle Cell | 2 | 2017 | 1018 | 0.340 |
Why?
|
Motor Cortex | 3 | 2023 | 986 | 0.330 |
Why?
|
Guidelines as Topic | 7 | 2013 | 1405 | 0.330 |
Why?
|
Adult | 89 | 2023 | 214055 | 0.320 |
Why?
|
Injections, Intra-Arterial | 7 | 2014 | 193 | 0.320 |
Why?
|
Documentation | 4 | 2018 | 871 | 0.320 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 8 | 2023 | 3255 | 0.310 |
Why?
|
Hypertension | 14 | 2023 | 8480 | 0.310 |
Why?
|
Prognosis | 28 | 2021 | 29063 | 0.310 |
Why?
|
Decision Making | 3 | 2018 | 3887 | 0.300 |
Why?
|
Anticonvulsants | 5 | 2021 | 1916 | 0.300 |
Why?
|
Length of Stay | 11 | 2019 | 6309 | 0.300 |
Why?
|
Hospital Units | 1 | 2008 | 141 | 0.300 |
Why?
|
Patient Satisfaction | 3 | 2019 | 3396 | 0.300 |
Why?
|
Deglutition Disorders | 2 | 2013 | 605 | 0.300 |
Why?
|
Anticholesteremic Agents | 3 | 2016 | 979 | 0.290 |
Why?
|
Cross Infection | 2 | 2013 | 1416 | 0.290 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2022 | 2208 | 0.290 |
Why?
|
Transportation of Patients | 5 | 2015 | 185 | 0.290 |
Why?
|
Blood Volume | 5 | 2017 | 565 | 0.280 |
Why?
|
Hyperglycemia | 1 | 2015 | 1373 | 0.280 |
Why?
|
Blood Coagulation Disorders | 1 | 2009 | 337 | 0.280 |
Why?
|
Hyperlipidemias | 3 | 2013 | 789 | 0.280 |
Why?
|
Brain | 35 | 2024 | 26385 | 0.280 |
Why?
|
Patient Readmission | 9 | 2020 | 3114 | 0.270 |
Why?
|
Patients | 2 | 2024 | 900 | 0.270 |
Why?
|
Cost-Benefit Analysis | 8 | 2021 | 5391 | 0.270 |
Why?
|
Cardiovascular Diseases | 11 | 2022 | 15165 | 0.270 |
Why?
|
Coronary Artery Disease | 7 | 2015 | 6487 | 0.260 |
Why?
|
Glasgow Coma Scale | 3 | 2019 | 570 | 0.260 |
Why?
|
Electronic Health Records | 6 | 2023 | 4468 | 0.260 |
Why?
|
Blood Coagulation Factors | 1 | 2008 | 355 | 0.260 |
Why?
|
Patient Preference | 3 | 2019 | 890 | 0.260 |
Why?
|
Stroke Volume | 6 | 2024 | 5007 | 0.260 |
Why?
|
Urban Population | 4 | 2021 | 2021 | 0.260 |
Why?
|
Brain Edema | 3 | 2014 | 617 | 0.260 |
Why?
|
Insurance, Health | 6 | 2023 | 2494 | 0.250 |
Why?
|
Fee-for-Service Plans | 4 | 2020 | 694 | 0.250 |
Why?
|
Massachusetts | 11 | 2021 | 8663 | 0.250 |
Why?
|
Data Collection | 7 | 2017 | 3341 | 0.250 |
Why?
|
Pneumonia | 2 | 2013 | 2133 | 0.250 |
Why?
|
Epilepsy | 4 | 2022 | 3310 | 0.250 |
Why?
|
Antithrombins | 2 | 2018 | 304 | 0.250 |
Why?
|
Cooperative Behavior | 5 | 2020 | 1504 | 0.250 |
Why?
|
Predictive Value of Tests | 21 | 2019 | 15076 | 0.250 |
Why?
|
Rural Population | 5 | 2022 | 2210 | 0.250 |
Why?
|
Injections, Intravenous | 7 | 2016 | 1420 | 0.240 |
Why?
|
Health Care Reform | 1 | 2014 | 1261 | 0.240 |
Why?
|
Amyotrophic Lateral Sclerosis | 3 | 2020 | 1414 | 0.240 |
Why?
|
Pregnancy Complications, Cardiovascular | 4 | 2015 | 500 | 0.240 |
Why?
|
Workflow | 5 | 2020 | 847 | 0.230 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2005 | 138 | 0.230 |
Why?
|
Ambulances | 3 | 2024 | 95 | 0.230 |
Why?
|
Policy | 2 | 2022 | 508 | 0.230 |
Why?
|
Glomerular Filtration Rate | 5 | 2018 | 2170 | 0.230 |
Why?
|
Poverty | 1 | 2015 | 2660 | 0.230 |
Why?
|
Biomedical Technology | 2 | 2018 | 220 | 0.230 |
Why?
|
Clinical Protocols | 4 | 2020 | 1462 | 0.230 |
Why?
|
Benchmarking | 4 | 2019 | 1042 | 0.230 |
Why?
|
Comorbidity | 15 | 2021 | 10388 | 0.230 |
Why?
|
Leukoaraiosis | 2 | 2015 | 120 | 0.230 |
Why?
|
Lipids | 2 | 2023 | 3305 | 0.230 |
Why?
|
Head Injuries, Closed | 1 | 2004 | 136 | 0.230 |
Why?
|
Health Services Accessibility | 8 | 2022 | 5137 | 0.230 |
Why?
|
Middle Cerebral Artery | 4 | 2012 | 264 | 0.220 |
Why?
|
Disease Progression | 5 | 2017 | 13284 | 0.220 |
Why?
|
Smoking Cessation | 6 | 2023 | 2071 | 0.220 |
Why?
|
Blood Pressure | 9 | 2023 | 8554 | 0.220 |
Why?
|
Follow-Up Studies | 25 | 2021 | 39050 | 0.220 |
Why?
|
China | 8 | 2022 | 2248 | 0.220 |
Why?
|
Brain Injuries | 1 | 2014 | 2025 | 0.220 |
Why?
|
Forecasting | 3 | 2020 | 2951 | 0.220 |
Why?
|
Critical Care | 3 | 2022 | 2647 | 0.220 |
Why?
|
Hospital Administrators | 1 | 2022 | 57 | 0.210 |
Why?
|
Angiography | 2 | 2005 | 1639 | 0.210 |
Why?
|
Survival Rate | 12 | 2021 | 12788 | 0.210 |
Why?
|
Case-Control Studies | 9 | 2021 | 21746 | 0.210 |
Why?
|
Linear Models | 6 | 2023 | 5952 | 0.210 |
Why?
|
Diabetes Complications | 3 | 2019 | 1359 | 0.210 |
Why?
|
Young Adult | 25 | 2022 | 56430 | 0.210 |
Why?
|
Image Processing, Computer-Assisted | 8 | 2014 | 8949 | 0.210 |
Why?
|
Magnetic Resonance Angiography | 9 | 2018 | 1442 | 0.200 |
Why?
|
Incidence | 13 | 2022 | 20947 | 0.200 |
Why?
|
Defibrillators, Implantable | 3 | 2017 | 1440 | 0.200 |
Why?
|
Pregnancy Complications | 1 | 2015 | 2861 | 0.200 |
Why?
|
Intracranial Arterial Diseases | 1 | 2021 | 22 | 0.200 |
Why?
|
Simvastatin | 1 | 2004 | 360 | 0.200 |
Why?
|
Cross-Sectional Studies | 9 | 2023 | 25043 | 0.200 |
Why?
|
Dependent Ambulation | 1 | 2021 | 13 | 0.200 |
Why?
|
Activities of Daily Living | 4 | 2022 | 2418 | 0.200 |
Why?
|
Amnesia, Transient Global | 1 | 2001 | 22 | 0.200 |
Why?
|
Encephalomyelitis, Eastern Equine | 1 | 2001 | 15 | 0.200 |
Why?
|
Angina, Unstable | 1 | 2006 | 926 | 0.200 |
Why?
|
Cost Savings | 4 | 2019 | 926 | 0.200 |
Why?
|
Primary Health Care | 2 | 2021 | 4558 | 0.190 |
Why?
|
Research Design | 4 | 2012 | 5987 | 0.190 |
Why?
|
Hospitals, Teaching | 4 | 2018 | 1179 | 0.190 |
Why?
|
Health Care Costs | 4 | 2021 | 3209 | 0.190 |
Why?
|
Heart Arrest | 3 | 2021 | 1470 | 0.190 |
Why?
|
Blood Glucose | 1 | 2015 | 6256 | 0.190 |
Why?
|
National Institutes of Health (U.S.) | 5 | 2015 | 780 | 0.190 |
Why?
|
Translating | 2 | 2022 | 144 | 0.190 |
Why?
|
Models, Statistical | 4 | 2014 | 5102 | 0.190 |
Why?
|
Awards and Prizes | 2 | 2017 | 375 | 0.190 |
Why?
|
Privacy | 1 | 2023 | 239 | 0.180 |
Why?
|
Adolescent | 27 | 2019 | 85781 | 0.180 |
Why?
|
Health Personnel | 5 | 2018 | 3218 | 0.180 |
Why?
|
Diagnosis, Differential | 9 | 2019 | 12959 | 0.180 |
Why?
|
Mobility Limitation | 2 | 2021 | 409 | 0.180 |
Why?
|
Feasibility Studies | 6 | 2020 | 5078 | 0.180 |
Why?
|
Insurance Benefits | 2 | 2020 | 183 | 0.180 |
Why?
|
Self Report | 2 | 2024 | 3558 | 0.170 |
Why?
|
Carotid Stenosis | 4 | 2018 | 854 | 0.170 |
Why?
|
Cerebral Arterial Diseases | 3 | 2016 | 82 | 0.170 |
Why?
|
Climatic Processes | 1 | 2018 | 3 | 0.170 |
Why?
|
Eligibility Determination | 2 | 2014 | 403 | 0.170 |
Why?
|
Organizational Innovation | 2 | 2021 | 559 | 0.170 |
Why?
|
Hospices | 2 | 2021 | 265 | 0.170 |
Why?
|
Patient Acceptance of Health Care | 3 | 2021 | 3022 | 0.170 |
Why?
|
Upper Extremity | 5 | 2023 | 648 | 0.170 |
Why?
|
Crowding | 1 | 2020 | 145 | 0.170 |
Why?
|
Starch | 1 | 2019 | 81 | 0.170 |
Why?
|
Infusions, Intra-Arterial | 4 | 2014 | 234 | 0.160 |
Why?
|
Organizational Objectives | 3 | 2017 | 438 | 0.160 |
Why?
|
Computers, Handheld | 2 | 2020 | 208 | 0.160 |
Why?
|
Point-of-Care Systems | 1 | 2007 | 1177 | 0.160 |
Why?
|
Communication | 2 | 2012 | 3749 | 0.160 |
Why?
|
Combined Modality Therapy | 6 | 2018 | 8642 | 0.160 |
Why?
|
Counseling | 3 | 2017 | 1523 | 0.160 |
Why?
|
Antihypertensive Agents | 4 | 2016 | 2046 | 0.160 |
Why?
|
Patient Care Team | 6 | 2017 | 2531 | 0.160 |
Why?
|
Drug Utilization | 2 | 2015 | 1183 | 0.160 |
Why?
|
Electrodes | 1 | 2020 | 619 | 0.150 |
Why?
|
Recombinant Proteins | 6 | 2017 | 6622 | 0.150 |
Why?
|
Pyramidal Tracts | 1 | 2019 | 256 | 0.150 |
Why?
|
Drug Therapy, Combination | 5 | 2022 | 6489 | 0.150 |
Why?
|
Thrombophlebitis | 1 | 1998 | 309 | 0.150 |
Why?
|
Quality-Adjusted Life Years | 3 | 2021 | 1683 | 0.150 |
Why?
|
International Classification of Diseases | 4 | 2019 | 867 | 0.150 |
Why?
|
Models, Organizational | 2 | 2012 | 574 | 0.150 |
Why?
|
Long-Term Care | 2 | 2013 | 607 | 0.150 |
Why?
|
Medical Audit | 3 | 2008 | 467 | 0.150 |
Why?
|
Hospitals, State | 1 | 2016 | 29 | 0.150 |
Why?
|
Comprehensive Health Care | 1 | 2018 | 127 | 0.150 |
Why?
|
Sample Size | 3 | 2023 | 845 | 0.150 |
Why?
|
Polyesters | 1 | 2019 | 363 | 0.150 |
Why?
|
Audiovisual Aids | 1 | 2017 | 92 | 0.150 |
Why?
|
Cardiovascular Agents | 2 | 2014 | 850 | 0.150 |
Why?
|
Post-Exposure Prophylaxis | 1 | 2018 | 102 | 0.150 |
Why?
|
Treatment Failure | 2 | 2021 | 2618 | 0.150 |
Why?
|
Troponin T | 2 | 2016 | 754 | 0.140 |
Why?
|
Eclampsia | 1 | 1997 | 58 | 0.140 |
Why?
|
Early Termination of Clinical Trials | 1 | 2016 | 68 | 0.140 |
Why?
|
Organizational Policy | 1 | 2019 | 429 | 0.140 |
Why?
|
Delayed Diagnosis | 1 | 2020 | 441 | 0.140 |
Why?
|
Socioeconomic Factors | 6 | 2017 | 7785 | 0.140 |
Why?
|
Diffusion of Innovation | 2 | 2019 | 725 | 0.140 |
Why?
|
Hemiplegia | 2 | 2016 | 135 | 0.140 |
Why?
|
Patient Education as Topic | 4 | 2017 | 2278 | 0.140 |
Why?
|
Aspirin | 8 | 2022 | 3282 | 0.140 |
Why?
|
Radiographic Image Enhancement | 2 | 2017 | 885 | 0.140 |
Why?
|
Quality of Life | 7 | 2021 | 12804 | 0.140 |
Why?
|
Hematoma | 2 | 2015 | 758 | 0.140 |
Why?
|
Reproducibility of Results | 16 | 2019 | 19905 | 0.140 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2001 | 652 | 0.140 |
Why?
|
Carotid Artery, Internal | 2 | 2012 | 445 | 0.140 |
Why?
|
Interdisciplinary Communication | 2 | 2020 | 950 | 0.140 |
Why?
|
International Normalized Ratio | 4 | 2023 | 367 | 0.140 |
Why?
|
Allied Health Personnel | 1 | 2017 | 162 | 0.140 |
Why?
|
Medicaid | 6 | 2023 | 2736 | 0.140 |
Why?
|
Shock | 1 | 2018 | 318 | 0.140 |
Why?
|
ROC Curve | 5 | 2017 | 3527 | 0.140 |
Why?
|
Risk | 9 | 2018 | 9687 | 0.140 |
Why?
|
Insurance Claim Review | 3 | 2021 | 720 | 0.130 |
Why?
|
Sensitivity and Specificity | 17 | 2015 | 14722 | 0.130 |
Why?
|
Health Expenditures | 2 | 2019 | 2348 | 0.130 |
Why?
|
Proxy | 1 | 2016 | 144 | 0.130 |
Why?
|
Europe | 4 | 2022 | 3339 | 0.130 |
Why?
|
Unnecessary Procedures | 1 | 2019 | 432 | 0.130 |
Why?
|
Recurrence | 6 | 2020 | 8340 | 0.130 |
Why?
|
Muscle Weakness | 1 | 2018 | 413 | 0.130 |
Why?
|
Hospital Bed Capacity | 3 | 2015 | 214 | 0.130 |
Why?
|
Carotid Artery, Common | 1 | 2016 | 183 | 0.130 |
Why?
|
HIV Protease Inhibitors | 1 | 1997 | 430 | 0.130 |
Why?
|
Diffusion | 7 | 2002 | 833 | 0.130 |
Why?
|
Infarction, Anterior Cerebral Artery | 1 | 2014 | 12 | 0.130 |
Why?
|
Aftercare | 4 | 2022 | 866 | 0.130 |
Why?
|
Hospice Care | 2 | 2019 | 672 | 0.120 |
Why?
|
Health Status | 4 | 2018 | 4034 | 0.120 |
Why?
|
Aphasia | 1 | 2016 | 179 | 0.120 |
Why?
|
Intracranial Thrombosis | 3 | 2006 | 113 | 0.120 |
Why?
|
Evidence-Based Practice | 3 | 2013 | 500 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2022 | 9959 | 0.120 |
Why?
|
Brain Stem | 2 | 2013 | 846 | 0.120 |
Why?
|
Health Knowledge, Attitudes, Practice | 4 | 2020 | 3923 | 0.120 |
Why?
|
Safety Management | 1 | 2020 | 783 | 0.120 |
Why?
|
Prescriptions | 2 | 2022 | 387 | 0.120 |
Why?
|
Diffuse Axonal Injury | 2 | 2004 | 49 | 0.120 |
Why?
|
Muscle Strength | 1 | 2018 | 592 | 0.120 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2018 | 501 | 0.120 |
Why?
|
Travel | 2 | 2019 | 788 | 0.120 |
Why?
|
Diabetes Mellitus | 6 | 2017 | 5751 | 0.120 |
Why?
|
Pelvis | 1 | 1998 | 730 | 0.120 |
Why?
|
Association | 1 | 2013 | 53 | 0.120 |
Why?
|
Specialization | 1 | 2019 | 777 | 0.120 |
Why?
|
Models, Theoretical | 3 | 2017 | 3589 | 0.120 |
Why?
|
Dyslipidemias | 2 | 2014 | 849 | 0.120 |
Why?
|
Health Resources | 2 | 2017 | 911 | 0.120 |
Why?
|
Dementia | 2 | 2022 | 2518 | 0.120 |
Why?
|
Pilot Projects | 6 | 2014 | 8324 | 0.120 |
Why?
|
Patient Advocacy | 2 | 2013 | 353 | 0.120 |
Why?
|
Self Care | 2 | 2018 | 786 | 0.110 |
Why?
|
Seizures | 3 | 2022 | 2859 | 0.110 |
Why?
|
Health Services Research | 4 | 2020 | 1836 | 0.110 |
Why?
|
Mortality | 2 | 2018 | 2864 | 0.110 |
Why?
|
Early Diagnosis | 3 | 2014 | 1184 | 0.110 |
Why?
|
Urban Health Services | 1 | 2014 | 179 | 0.110 |
Why?
|
Algorithms | 9 | 2023 | 13881 | 0.110 |
Why?
|
Ambulatory Care | 2 | 2021 | 2708 | 0.110 |
Why?
|
Health Care Surveys | 4 | 2017 | 2453 | 0.110 |
Why?
|
Venous Thromboembolism | 2 | 2018 | 1671 | 0.110 |
Why?
|
Hemorrhage | 4 | 2023 | 3461 | 0.110 |
Why?
|
Basilar Artery | 2 | 2022 | 200 | 0.110 |
Why?
|
Psychomotor Performance | 1 | 2021 | 1901 | 0.110 |
Why?
|
Blood Volume Determination | 1 | 2012 | 43 | 0.110 |
Why?
|
Myocardial Revascularization | 2 | 2014 | 841 | 0.110 |
Why?
|
Meninges | 1 | 2014 | 190 | 0.110 |
Why?
|
Ventricular Function, Left | 3 | 2022 | 3670 | 0.110 |
Why?
|
Cardiology Service, Hospital | 1 | 2014 | 246 | 0.110 |
Why?
|
Clinical Audit | 1 | 2012 | 31 | 0.110 |
Why?
|
Proportional Hazards Models | 6 | 2020 | 12354 | 0.110 |
Why?
|
Cerebral Arteries | 2 | 2009 | 494 | 0.100 |
Why?
|
Consensus | 2 | 2021 | 2959 | 0.100 |
Why?
|
Brain Mapping | 4 | 2020 | 6669 | 0.100 |
Why?
|
Credentialing | 1 | 2012 | 126 | 0.100 |
Why?
|
Patient Participation | 1 | 2021 | 1457 | 0.100 |
Why?
|
Internet | 4 | 2012 | 3064 | 0.100 |
Why?
|
Injections, Epidural | 1 | 2013 | 195 | 0.100 |
Why?
|
Licensure | 1 | 2012 | 124 | 0.100 |
Why?
|
Tissue Donors | 1 | 2021 | 2240 | 0.100 |
Why?
|
Online Systems | 1 | 2012 | 184 | 0.100 |
Why?
|
Angiotensin Receptor Antagonists | 2 | 2014 | 924 | 0.100 |
Why?
|
Balloon Occlusion | 1 | 2012 | 126 | 0.100 |
Why?
|
Incidental Findings | 1 | 2016 | 689 | 0.100 |
Why?
|
Glycyrrhiza | 1 | 2010 | 11 | 0.100 |
Why?
|
Statistics, Nonparametric | 3 | 2018 | 2886 | 0.100 |
Why?
|
Remission, Spontaneous | 1 | 2011 | 382 | 0.100 |
Why?
|
Health Facility Size | 1 | 2010 | 64 | 0.090 |
Why?
|
Peripartum Period | 1 | 2012 | 133 | 0.090 |
Why?
|
Hospitals, Rural | 2 | 2022 | 172 | 0.090 |
Why?
|
Prevalence | 8 | 2022 | 15226 | 0.090 |
Why?
|
Computer Systems | 1 | 2012 | 483 | 0.090 |
Why?
|
Perfusion | 6 | 2024 | 1360 | 0.090 |
Why?
|
Population Surveillance | 2 | 2015 | 2616 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2014 | 1518 | 0.090 |
Why?
|
Neurofibromatosis 1 | 1 | 2015 | 569 | 0.090 |
Why?
|
Cerebrospinal Fluid | 1 | 2013 | 534 | 0.090 |
Why?
|
Multilevel Analysis | 1 | 2010 | 142 | 0.090 |
Why?
|
Acute Coronary Syndrome | 2 | 2014 | 2337 | 0.090 |
Why?
|
Social Class | 1 | 2019 | 1999 | 0.090 |
Why?
|
Survival Analysis | 6 | 2015 | 10252 | 0.090 |
Why?
|
Posterior Leukoencephalopathy Syndrome | 1 | 2010 | 53 | 0.090 |
Why?
|
Public Health Administration | 1 | 2012 | 240 | 0.090 |
Why?
|
Clinical Chemistry Tests | 1 | 2009 | 61 | 0.090 |
Why?
|
Decision Support Systems, Clinical | 2 | 2021 | 1164 | 0.090 |
Why?
|
Hypercholesterolemia | 1 | 2016 | 1151 | 0.090 |
Why?
|
Canada | 1 | 2015 | 2065 | 0.090 |
Why?
|
Technetium Tc 99m Exametazime | 1 | 2009 | 68 | 0.090 |
Why?
|
Clinical Medicine | 1 | 2011 | 147 | 0.090 |
Why?
|
Uncertainty | 1 | 2014 | 734 | 0.090 |
Why?
|
Clinical Trials as Topic | 8 | 2014 | 7913 | 0.090 |
Why?
|
Computer Simulation | 5 | 2022 | 6196 | 0.090 |
Why?
|
Home Care Services | 1 | 2016 | 606 | 0.090 |
Why?
|
Risk Management | 1 | 2013 | 571 | 0.090 |
Why?
|
Paresis | 3 | 2006 | 179 | 0.090 |
Why?
|
Hematoma, Subdural, Intracranial | 2 | 2006 | 33 | 0.090 |
Why?
|
Critical Pathways | 2 | 2015 | 476 | 0.090 |
Why?
|
Circle of Willis | 1 | 2009 | 68 | 0.090 |
Why?
|
Renin-Angiotensin System | 1 | 2014 | 759 | 0.090 |
Why?
|
Oscillometry | 1 | 2009 | 147 | 0.080 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2016 | 980 | 0.080 |
Why?
|
Regression Analysis | 4 | 2018 | 6459 | 0.080 |
Why?
|
Drug Interactions | 2 | 2008 | 1460 | 0.080 |
Why?
|
Aorta, Abdominal | 1 | 2012 | 646 | 0.080 |
Why?
|
Bayes Theorem | 1 | 2017 | 2309 | 0.080 |
Why?
|
Age of Onset | 1 | 2015 | 3271 | 0.080 |
Why?
|
Corpus Callosum | 2 | 2022 | 737 | 0.080 |
Why?
|
False Positive Reactions | 2 | 2009 | 981 | 0.080 |
Why?
|
Perception | 1 | 2015 | 1198 | 0.080 |
Why?
|
Research | 1 | 2017 | 1999 | 0.080 |
Why?
|
History, 21st Century | 2 | 2012 | 1534 | 0.080 |
Why?
|
Vascular Diseases | 1 | 1997 | 1161 | 0.080 |
Why?
|
Physicians | 4 | 2018 | 4567 | 0.080 |
Why?
|
Data Interpretation, Statistical | 3 | 2014 | 2716 | 0.080 |
Why?
|
Microbubbles | 1 | 2009 | 128 | 0.080 |
Why?
|
Disease Management | 4 | 2020 | 2459 | 0.080 |
Why?
|
Risk Reduction Behavior | 3 | 2012 | 1125 | 0.080 |
Why?
|
Pyridones | 3 | 2018 | 712 | 0.080 |
Why?
|
Blood Flow Velocity | 4 | 2012 | 1423 | 0.080 |
Why?
|
California | 2 | 2023 | 1402 | 0.080 |
Why?
|
Stents | 2 | 2018 | 3280 | 0.080 |
Why?
|
Kidney Diseases | 2 | 2016 | 2149 | 0.080 |
Why?
|
Chronic Disease | 4 | 2017 | 9146 | 0.080 |
Why?
|
Women | 1 | 2009 | 230 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2014 | 804 | 0.080 |
Why?
|
Echocardiography | 5 | 2022 | 5102 | 0.080 |
Why?
|
Elastomers | 1 | 2008 | 71 | 0.080 |
Why?
|
Vasoconstriction | 1 | 2010 | 597 | 0.080 |
Why?
|
Angioplasty, Balloon | 2 | 2012 | 653 | 0.080 |
Why?
|
Accreditation | 1 | 2010 | 450 | 0.080 |
Why?
|
Coronary Artery Bypass | 2 | 2014 | 2289 | 0.080 |
Why?
|
Antidepressive Agents | 2 | 2021 | 2838 | 0.080 |
Why?
|
Software | 2 | 2020 | 4443 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2014 | 1257 | 0.070 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 114 | 0.070 |
Why?
|
Ticlopidine | 2 | 2010 | 899 | 0.070 |
Why?
|
Pregnancy | 8 | 2022 | 29144 | 0.070 |
Why?
|
Single-Blind Method | 4 | 2018 | 1590 | 0.070 |
Why?
|
Image Enhancement | 2 | 2011 | 2921 | 0.070 |
Why?
|
Phenylephrine | 2 | 1998 | 301 | 0.070 |
Why?
|
Total Quality Management | 1 | 2008 | 274 | 0.070 |
Why?
|
Reimbursement, Incentive | 1 | 2012 | 540 | 0.070 |
Why?
|
Health Priorities | 1 | 2010 | 380 | 0.070 |
Why?
|
Mental Status Schedule | 1 | 1987 | 321 | 0.070 |
Why?
|
Fibrinogen | 1 | 2010 | 894 | 0.070 |
Why?
|
Family | 1 | 2017 | 3147 | 0.070 |
Why?
|
National Health Programs | 1 | 2010 | 445 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2020 | 2758 | 0.070 |
Why?
|
Cerebral Revascularization | 1 | 2009 | 238 | 0.070 |
Why?
|
Biomedical Research | 3 | 2012 | 3309 | 0.070 |
Why?
|
Reimbursement Mechanisms | 1 | 2012 | 670 | 0.070 |
Why?
|
Hospitals, Community | 1 | 2008 | 348 | 0.070 |
Why?
|
Intensive Care Units | 1 | 2019 | 3679 | 0.070 |
Why?
|
Interviews as Topic | 3 | 2020 | 2539 | 0.070 |
Why?
|
Cerebellum | 1 | 2013 | 1488 | 0.070 |
Why?
|
Meta-Analysis as Topic | 1 | 2011 | 1344 | 0.070 |
Why?
|
Brain Concussion | 1 | 2017 | 1320 | 0.070 |
Why?
|
Clinical Competence | 3 | 2018 | 4687 | 0.070 |
Why?
|
Arteriovenous Malformations | 1 | 2009 | 396 | 0.070 |
Why?
|
Michigan | 3 | 2017 | 350 | 0.070 |
Why?
|
Heart Atria | 2 | 2023 | 1357 | 0.070 |
Why?
|
Health Education | 3 | 2010 | 1056 | 0.070 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 2006 | 105 | 0.070 |
Why?
|
Mental Health Services | 1 | 2017 | 1643 | 0.070 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2009 | 957 | 0.070 |
Why?
|
Information Dissemination | 1 | 2014 | 1099 | 0.070 |
Why?
|
Terminology as Topic | 2 | 2010 | 1547 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2013 | 1573 | 0.060 |
Why?
|
Brain Diseases | 2 | 2020 | 1563 | 0.060 |
Why?
|
Cholesterol, LDL | 1 | 2014 | 2356 | 0.060 |
Why?
|
Disabled Persons | 1 | 2014 | 1212 | 0.060 |
Why?
|
Rural Health Services | 1 | 2008 | 379 | 0.060 |
Why?
|
Boston | 4 | 2013 | 9313 | 0.060 |
Why?
|
Speech Disorders | 2 | 2004 | 189 | 0.060 |
Why?
|
Electrocardiography | 3 | 2021 | 6442 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2010 | 840 | 0.060 |
Why?
|
Drug Prescriptions | 2 | 2012 | 1637 | 0.060 |
Why?
|
Plasma | 1 | 2008 | 575 | 0.060 |
Why?
|
Time and Motion Studies | 2 | 2014 | 149 | 0.060 |
Why?
|
Venous Thrombosis | 2 | 2014 | 1239 | 0.060 |
Why?
|
Longitudinal Studies | 5 | 2019 | 13989 | 0.060 |
Why?
|
Carotid Artery Thrombosis | 1 | 2004 | 53 | 0.060 |
Why?
|
Analgesia, Obstetrical | 1 | 2006 | 177 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2016 | 2872 | 0.060 |
Why?
|
Vasoconstrictor Agents | 2 | 1998 | 642 | 0.060 |
Why?
|
Tomography, Spiral Computed | 1 | 2006 | 280 | 0.060 |
Why?
|
Spectroscopy, Near-Infrared | 1 | 2009 | 721 | 0.060 |
Why?
|
Equipment Design | 2 | 2009 | 3582 | 0.060 |
Why?
|
Sleep | 1 | 2020 | 4623 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2009 | 1107 | 0.060 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2005 | 153 | 0.060 |
Why?
|
Pyrrolidines | 1 | 2006 | 342 | 0.060 |
Why?
|
Alanine | 1 | 2006 | 572 | 0.060 |
Why?
|
Aging | 2 | 2014 | 8664 | 0.060 |
Why?
|
Sympathetic Nervous System | 1 | 2006 | 514 | 0.060 |
Why?
|
Brain Damage, Chronic | 1 | 2004 | 265 | 0.060 |
Why?
|
Hemodynamics | 3 | 2020 | 4199 | 0.060 |
Why?
|
North America | 2 | 2020 | 1249 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4931 | 0.060 |
Why?
|
United States Food and Drug Administration | 2 | 2021 | 1584 | 0.050 |
Why?
|
Analgesia, Epidural | 1 | 2006 | 327 | 0.050 |
Why?
|
Pyrazoles | 3 | 2018 | 1972 | 0.050 |
Why?
|
Respiration | 1 | 2009 | 1653 | 0.050 |
Why?
|
Syndrome | 2 | 2006 | 3251 | 0.050 |
Why?
|
Cardiology | 1 | 2013 | 1668 | 0.050 |
Why?
|
Case Management | 1 | 2004 | 286 | 0.050 |
Why?
|
Intracranial Embolism | 1 | 2004 | 202 | 0.050 |
Why?
|
Models, Biological | 2 | 2017 | 9583 | 0.050 |
Why?
|
Vital Statistics | 1 | 2021 | 34 | 0.050 |
Why?
|
Heart Septum | 1 | 2003 | 313 | 0.050 |
Why?
|
Anti-HIV Agents | 1 | 1997 | 4256 | 0.050 |
Why?
|
India | 2 | 2018 | 2197 | 0.050 |
Why?
|
Embolism | 2 | 2018 | 408 | 0.050 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 1 | 2008 | 1184 | 0.050 |
Why?
|
Neoplasms | 1 | 2010 | 21683 | 0.050 |
Why?
|
Air Ambulances | 1 | 2002 | 90 | 0.050 |
Why?
|
Kidney Function Tests | 2 | 2014 | 684 | 0.050 |
Why?
|
Carcinoma, Renal Cell | 1 | 2016 | 3143 | 0.050 |
Why?
|
Hotlines | 1 | 2020 | 55 | 0.050 |
Why?
|
Brain Neoplasms | 2 | 2021 | 8863 | 0.050 |
Why?
|
Hospitals, Urban | 1 | 2022 | 499 | 0.050 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2021 | 288 | 0.050 |
Why?
|
Medical Records Systems, Computerized | 1 | 2006 | 1205 | 0.050 |
Why?
|
Mental Health | 1 | 2014 | 3019 | 0.050 |
Why?
|
Echo-Planar Imaging | 3 | 2005 | 659 | 0.040 |
Why?
|
Medication Adherence | 1 | 2011 | 2063 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 478 | 0.040 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2014 | 3327 | 0.040 |
Why?
|
HIV Infections | 2 | 2014 | 16718 | 0.040 |
Why?
|
Walking | 2 | 2018 | 1180 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4262 | 0.040 |
Why?
|
Child | 5 | 2019 | 77709 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2004 | 1092 | 0.040 |
Why?
|
Contrast Media | 4 | 2008 | 5300 | 0.040 |
Why?
|
Double-Blind Method | 3 | 2024 | 12026 | 0.040 |
Why?
|
Vasospasm, Intracranial | 1 | 2001 | 208 | 0.040 |
Why?
|
Heart Diseases | 4 | 2018 | 2788 | 0.040 |
Why?
|
Hypolipidemic Agents | 2 | 2014 | 604 | 0.040 |
Why?
|
Rain | 1 | 2018 | 61 | 0.040 |
Why?
|
Lipid Peroxides | 1 | 1998 | 73 | 0.040 |
Why?
|
Survivors | 2 | 2021 | 2291 | 0.040 |
Why?
|
Sick Leave | 1 | 2019 | 110 | 0.040 |
Why?
|
Age Distribution | 2 | 2018 | 2902 | 0.040 |
Why?
|
Thrombosis | 2 | 2010 | 2968 | 0.040 |
Why?
|
Feedback | 1 | 2022 | 795 | 0.040 |
Why?
|
Regional Blood Flow | 2 | 2014 | 1525 | 0.040 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2022 | 841 | 0.040 |
Why?
|
Antidotes | 1 | 2018 | 138 | 0.040 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2023 | 859 | 0.040 |
Why?
|
Communication Barriers | 1 | 2021 | 398 | 0.040 |
Why?
|
Disease-Free Survival | 2 | 2019 | 6895 | 0.040 |
Why?
|
Rupture, Spontaneous | 1 | 2018 | 354 | 0.040 |
Why?
|
Internship and Residency | 1 | 2018 | 5788 | 0.040 |
Why?
|
Carotid Artery Diseases | 1 | 2024 | 882 | 0.040 |
Why?
|
Phenytoin | 1 | 1997 | 197 | 0.040 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1987 | 6038 | 0.040 |
Why?
|
Confidence Intervals | 2 | 2013 | 2971 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 1999 | 1681 | 0.040 |
Why?
|
Phenobarbital | 1 | 1997 | 193 | 0.040 |
Why?
|
Hospitals, Public | 1 | 2018 | 207 | 0.040 |
Why?
|
Radioisotope Teletherapy | 1 | 1996 | 18 | 0.040 |
Why?
|
Carbamazepine | 1 | 1997 | 229 | 0.040 |
Why?
|
Bulbar Palsy, Progressive | 1 | 1996 | 10 | 0.040 |
Why?
|
Cranial Nerve Injuries | 1 | 1996 | 25 | 0.040 |
Why?
|
Benzodiazepines | 1 | 2022 | 1101 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15295 | 0.040 |
Why?
|
Cobalt Radioisotopes | 1 | 1996 | 76 | 0.040 |
Why?
|
Electrodes, Implanted | 1 | 2021 | 824 | 0.040 |
Why?
|
Caregivers | 2 | 2019 | 2094 | 0.040 |
Why?
|
Demography | 1 | 2001 | 1656 | 0.040 |
Why?
|
Systole | 1 | 2019 | 958 | 0.030 |
Why?
|
Personnel, Hospital | 1 | 2018 | 283 | 0.030 |
Why?
|
Georgia | 2 | 2006 | 186 | 0.030 |
Why?
|
Heart | 1 | 2009 | 4467 | 0.030 |
Why?
|
Monitoring, Physiologic | 1 | 2023 | 1738 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2015 | 4933 | 0.030 |
Why?
|
Medication Therapy Management | 1 | 2016 | 127 | 0.030 |
Why?
|
Depression | 1 | 2015 | 7766 | 0.030 |
Why?
|
Ohio | 2 | 2006 | 337 | 0.030 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 1997 | 419 | 0.030 |
Why?
|
Sex Distribution | 2 | 2012 | 2297 | 0.030 |
Why?
|
Emergency Medicine | 1 | 2004 | 1207 | 0.030 |
Why?
|
Fibrinolysis | 1 | 2016 | 322 | 0.030 |
Why?
|
Tomography Scanners, X-Ray Computed | 1 | 2015 | 168 | 0.030 |
Why?
|
Life Expectancy | 1 | 2021 | 1184 | 0.030 |
Why?
|
Neuropsychological Tests | 1 | 1987 | 6993 | 0.030 |
Why?
|
Housing | 1 | 2019 | 664 | 0.030 |
Why?
|
Anesthesia Department, Hospital | 1 | 2014 | 68 | 0.030 |
Why?
|
Health Promotion | 1 | 2006 | 2205 | 0.030 |
Why?
|
Hospital Costs | 1 | 2020 | 985 | 0.030 |
Why?
|
Electroencephalography | 1 | 2009 | 6150 | 0.030 |
Why?
|
Fever | 1 | 2001 | 1616 | 0.030 |
Why?
|
Selection Bias | 1 | 2015 | 371 | 0.030 |
Why?
|
Computers | 1 | 2016 | 612 | 0.030 |
Why?
|
Population | 1 | 2013 | 142 | 0.030 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 1996 | 286 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2019 | 1681 | 0.030 |
Why?
|
Directive Counseling | 1 | 2014 | 166 | 0.030 |
Why?
|
London | 1 | 2013 | 233 | 0.030 |
Why?
|
Punctures | 1 | 2014 | 374 | 0.030 |
Why?
|
England | 1 | 2014 | 522 | 0.030 |
Why?
|
Cognition Disorders | 1 | 1987 | 4043 | 0.030 |
Why?
|
Vasodilation | 1 | 1997 | 944 | 0.030 |
Why?
|
Myocardium | 1 | 2006 | 4776 | 0.030 |
Why?
|
Isoenzymes | 1 | 1997 | 1726 | 0.030 |
Why?
|
Seasons | 1 | 2018 | 1493 | 0.030 |
Why?
|
Action Potentials | 1 | 2020 | 1806 | 0.030 |
Why?
|
Learning | 1 | 2022 | 1713 | 0.030 |
Why?
|
Temperature | 1 | 2018 | 2206 | 0.030 |
Why?
|
Review Literature as Topic | 1 | 2014 | 336 | 0.030 |
Why?
|
Nursing Methodology Research | 1 | 2011 | 67 | 0.030 |
Why?
|
Achievement | 1 | 2013 | 291 | 0.030 |
Why?
|
Emergency Nursing | 1 | 2011 | 45 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2029 | 0.030 |
Why?
|
Hematologic Tests | 1 | 2013 | 240 | 0.030 |
Why?
|
Professional-Patient Relations | 1 | 2017 | 737 | 0.030 |
Why?
|
Constriction, Pathologic | 1 | 2015 | 1107 | 0.020 |
Why?
|
Licensure, Hospital | 1 | 2010 | 3 | 0.020 |
Why?
|
Patient Protection and Affordable Care Act | 1 | 2021 | 1209 | 0.020 |
Why?
|
Pregnancy Outcome | 2 | 2015 | 2795 | 0.020 |
Why?
|
Nimodipine | 1 | 2010 | 55 | 0.020 |
Why?
|
Leadership | 1 | 2020 | 1357 | 0.020 |
Why?
|
Coronary Disease | 1 | 2006 | 6077 | 0.020 |
Why?
|
Time | 2 | 2002 | 542 | 0.020 |
Why?
|
Headache Disorders, Primary | 1 | 2010 | 36 | 0.020 |
Why?
|
State Government | 1 | 2013 | 372 | 0.020 |
Why?
|
Obsessive Behavior | 1 | 2010 | 47 | 0.020 |
Why?
|
Risk Adjustment | 1 | 2014 | 594 | 0.020 |
Why?
|
Verapamil | 1 | 2010 | 244 | 0.020 |
Why?
|
Hyperhomocysteinemia | 1 | 2010 | 124 | 0.020 |
Why?
|
Private Sector | 1 | 2013 | 392 | 0.020 |
Why?
|
Medical Records | 1 | 2015 | 1413 | 0.020 |
Why?
|
Health Planning Support | 1 | 2009 | 9 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3584 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 2006 | 5708 | 0.020 |
Why?
|
Patient Care Planning | 1 | 2015 | 921 | 0.020 |
Why?
|
Cost of Illness | 1 | 2019 | 1859 | 0.020 |
Why?
|
Renal Dialysis | 1 | 2018 | 1786 | 0.020 |
Why?
|
Endpoint Determination | 1 | 2012 | 601 | 0.020 |
Why?
|
Thiazoles | 1 | 2016 | 1483 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2002 | 4042 | 0.020 |
Why?
|
Animals | 3 | 2017 | 168757 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1240 | 0.020 |
Why?
|
Creatinine | 1 | 2014 | 1919 | 0.020 |
Why?
|
Heart Rate | 1 | 2020 | 4091 | 0.020 |
Why?
|
Radiation Injuries | 1 | 1996 | 1180 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3605 | 0.020 |
Why?
|
Propensity Score | 1 | 2015 | 1781 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 2017 | 1541 | 0.020 |
Why?
|
Phenotype | 2 | 2022 | 16365 | 0.020 |
Why?
|
Motor Activity | 1 | 2018 | 2714 | 0.020 |
Why?
|
Dipyridamole | 1 | 2008 | 145 | 0.020 |
Why?
|
Technology | 1 | 2010 | 305 | 0.020 |
Why?
|
Organizational Culture | 1 | 2011 | 510 | 0.020 |
Why?
|
Thrombophilia | 1 | 2010 | 305 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 977 | 0.020 |
Why?
|
Terminal Care | 1 | 2019 | 1694 | 0.020 |
Why?
|
Plaque, Atherosclerotic | 1 | 2018 | 1519 | 0.020 |
Why?
|
False Negative Reactions | 1 | 1987 | 588 | 0.020 |
Why?
|
Carcinoma, Transitional Cell | 1 | 1993 | 808 | 0.020 |
Why?
|
Vasodilator Agents | 1 | 2010 | 977 | 0.020 |
Why?
|
Artifacts | 1 | 2014 | 1904 | 0.020 |
Why?
|
Blood Patch, Epidural | 1 | 2006 | 59 | 0.020 |
Why?
|
Minority Groups | 1 | 2013 | 1223 | 0.020 |
Why?
|
Hospital Records | 1 | 2005 | 95 | 0.020 |
Why?
|
Iohexol | 1 | 2006 | 196 | 0.020 |
Why?
|
Pyridines | 1 | 2016 | 2825 | 0.020 |
Why?
|
Carcinoma | 1 | 1996 | 2375 | 0.020 |
Why?
|
Child, Preschool | 2 | 2004 | 41006 | 0.020 |
Why?
|
Pressure | 1 | 2008 | 1203 | 0.020 |
Why?
|
Meningeal Neoplasms | 1 | 1993 | 1241 | 0.010 |
Why?
|
Peer Review, Health Care | 1 | 2004 | 75 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2013 | 6365 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2009 | 1677 | 0.010 |
Why?
|
Cognition | 1 | 2021 | 6770 | 0.010 |
Why?
|
International Cooperation | 1 | 2010 | 1420 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2009 | 969 | 0.010 |
Why?
|
Vision Disorders | 1 | 2010 | 1058 | 0.010 |
Why?
|
Qualitative Research | 1 | 2011 | 2682 | 0.010 |
Why?
|
Maternal Age | 1 | 2006 | 802 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10943 | 0.010 |
Why?
|
Random Allocation | 1 | 1987 | 2429 | 0.010 |
Why?
|
Echocardiography, Transesophageal | 1 | 2009 | 1133 | 0.010 |
Why?
|
Body Fluid Compartments | 1 | 2002 | 52 | 0.010 |
Why?
|
Hydrocortisone | 1 | 2010 | 1826 | 0.010 |
Why?
|
Drug Combinations | 1 | 2008 | 1959 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6538 | 0.010 |
Why?
|
Intracranial Aneurysm | 1 | 2012 | 1197 | 0.010 |
Why?
|
Quality Control | 1 | 2005 | 841 | 0.010 |
Why?
|
History, 20th Century | 1 | 2010 | 2740 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2008 | 2373 | 0.010 |
Why?
|
Consciousness Disorders | 1 | 2006 | 418 | 0.010 |
Why?
|
Necrosis | 1 | 2006 | 1643 | 0.010 |
Why?
|
Health Status Disparities | 1 | 2013 | 1797 | 0.010 |
Why?
|
Parietal Lobe | 1 | 2006 | 838 | 0.010 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1993 | 2245 | 0.010 |
Why?
|
Anisotropy | 1 | 2004 | 1265 | 0.010 |
Why?
|
Air Pollution | 1 | 2013 | 2286 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2012 | 2376 | 0.010 |
Why?
|
Brain Stem Infarctions | 1 | 1999 | 32 | 0.010 |
Why?
|
Conflict of Interest | 1 | 2004 | 544 | 0.010 |
Why?
|
Health Surveys | 1 | 2009 | 4037 | 0.010 |
Why?
|
Cholesterol Esters | 1 | 1998 | 73 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2017 | 18029 | 0.010 |
Why?
|
Patient Compliance | 1 | 2009 | 2684 | 0.010 |
Why?
|
Differential Threshold | 1 | 1997 | 80 | 0.010 |
Why?
|
Microcirculation | 1 | 2002 | 1286 | 0.010 |
Why?
|
Obesity | 2 | 2013 | 12745 | 0.010 |
Why?
|
Gestational Age | 1 | 2006 | 3493 | 0.010 |
Why?
|
Exercise | 1 | 2013 | 5615 | 0.010 |
Why?
|
Public Health | 1 | 2010 | 2603 | 0.010 |
Why?
|
Observer Variation | 1 | 2002 | 2593 | 0.010 |
Why?
|
Neck Muscles | 1 | 1996 | 104 | 0.010 |
Why?
|
Cranial Nerves | 1 | 1996 | 101 | 0.010 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2006 | 2282 | 0.010 |
Why?
|
Pneumonia, Aspiration | 1 | 1996 | 145 | 0.010 |
Why?
|
Water | 1 | 2001 | 1395 | 0.010 |
Why?
|
Ascorbic Acid | 1 | 1998 | 651 | 0.010 |
Why?
|
Neck Injuries | 1 | 1996 | 152 | 0.010 |
Why?
|
Cachexia | 1 | 1996 | 204 | 0.010 |
Why?
|
Causality | 1 | 2001 | 1275 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2010 | 3445 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2006 | 3966 | 0.010 |
Why?
|
Safety | 1 | 1997 | 1186 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 1998 | 1026 | 0.010 |
Why?
|
Electromyography | 1 | 1996 | 1379 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2004 | 3229 | 0.010 |
Why?
|
Enteral Nutrition | 1 | 1996 | 763 | 0.010 |
Why?
|
Neoplasms, Multiple Primary | 1 | 1993 | 604 | 0.010 |
Why?
|
Dyspnea | 1 | 1996 | 1303 | 0.000 |
Why?
|
Homeostasis | 1 | 1998 | 3340 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2001 | 25625 | 0.000 |
Why?
|
Infant | 1 | 2001 | 35136 | 0.000 |
Why?
|